Information
Learning Objective 1
Name mTOR pathway gene variants associated with mTORopathies
Learning Objective 2
Define the pathological and clinical features of mTORopathies
Learning Objective 3
Describe the role and efficacy of mTOR inhibitors in clinical epilepsy;sy care in mTORopathies
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)AdvocatesBehavioral Health ProvidersCommunity Health WorkersNursesPharmacistsScientists/ResearchersSocial WorkersTechnicians
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalFirst-time AttendeesYoung ProfessionalsResearch
Session ID
LOMLEC26
Presentation Id
3451818
Event ID
24056
Session Type
Session

